Core Viewpoint - Southbound funds increased their holdings in Jinxin Fertility (01951.HK) by 4.53 million shares on December 10, indicating a positive sentiment towards the company despite recent fluctuations in trading volume [1] Group 1: Southbound Fund Activity - In the last 5 trading days, southbound funds reduced their holdings on 4 days, with a total net reduction of 16.03 million shares [1] - Over the past 20 trading days, southbound funds increased their holdings on 14 days, resulting in a total net increase of 18.23 million shares [1] - Currently, southbound funds hold 1.465 billion shares of Jinxin Fertility, accounting for 53.1% of the company's total issued ordinary shares [1] Group 2: Company Overview - Jinxin Fertility Medical Group Limited is an investment holding company primarily providing in vitro fertilization (IVF) services [1] - The company offers a range of services through its subsidiaries, including assisted reproductive services, management services, ambulatory surgical center facilities, auxiliary medical services, and maternal and pediatric medical services [1] - Jinxin Fertility operates mainly in China and the United States, also engaging in the sale of medical consumables and equipment [1]

Core Viewpoint - Jinxin Fertility (01951.HK) announced a share buyback on December 10, 2023, spending HKD 4.766 million to repurchase 1.926 million shares at a price range of HKD 2.43 to 2.49 per share [1] Summary by Category - **Company Actions** - The company executed a buyback of 1.926 million shares at a total cost of HKD 4.766 million [1] - The repurchase price per share ranged from HKD 2.43 to HKD 2.49 [1]

Core Viewpoint - The company, Jinxin Reproductive Medicine (01951), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Company Actions - The company plans to repurchase 1,925,500 shares at a total cost of HKD 4.766 million [1]

Group 1 - The company, Jinxin Reproductive Medicine (01951), announced a share buyback plan, intending to repurchase 1.9255 million shares at a cost of HKD 4.766 million [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 公司名稱： 錦欣生殖醫療集團有限公司 呈交日期： 2025年12月10日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01951 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不 ...

Core Viewpoint - Jinxin Reproductive (01951) announced a share buyback plan, indicating confidence in its stock value and potential for future growth [2] Group 1: Share Buyback Details - The company plans to repurchase 3.802 million shares at a total cost of HKD 9.2077 million [2] - The buyback price per share is set between HKD 2.4 and HKD 2.5 [2]

Core Viewpoint - Southbound funds have reduced their holdings in Jinxin Fertility (01951.HK) by 11.989 million shares on December 9, indicating a trend of net selling over recent trading days [1] Group 1: Southbound Fund Activity - In the last 5 trading days, southbound funds have reduced their holdings for 5 days, with a total net reduction of 24.8715 million shares [1] - Over the past 20 trading days, there have been 13 days of net increases in holdings by southbound funds, totaling a net increase of 9.3238 million shares [1] - Currently, southbound funds hold 1.46 billion shares of Jinxin Fertility, accounting for 52.94% of the company's issued ordinary shares [1] Group 2: Company Overview - Jinxin Fertility Medical Group Limited is an investment holding company primarily providing in vitro fertilization (IVF) services [1] - The company offers assisted reproductive services, management services, ambulatory surgical center facility services, auxiliary medical services, obstetrics and pediatrics medical services, as well as sales of medical consumables and equipment [1] - Jinxin Fertility operates mainly in China and the United States [1]

Core Viewpoint - The company, Jinxin Fertility (01951), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Share Buyback Details - The company plans to repurchase 3.802 million shares at a total cost of HKD 9.2077 million [1] - The buyback price per share is set between HKD 2.4 and HKD 2.5 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) | 1). | 購回股份擬註銷但尚未註銷 | | 7,722,000 | 0.28 % | HKD | 2.5638 | | --- | --- | --- | --- | --- | --- | --- | | | 變動日期 | 2025年12月5日 | | | | | | 2). | 購回股份擬註銷但尚未註銷 | | 5,928,500 | 0.22 % | HKD | 2.5047 | | | 變動日期 | 2025年12月8日 | | | | | | 3). | 購回股份擬註銷但尚未註銷 | | 3,802,000 | 0.14 % | HKD | 2.4218 | | | 變動日期 | 2025年12月9日 | | | | | 表格類別： 股票 狀態： 新提交 公司名稱： 錦欣生殖醫療集團有限公司 呈交日期： 2025年12月9日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交 ...

Summary of Key Points Core Viewpoint - On December 8, 49 Hong Kong-listed companies conducted share buybacks, totaling 45.44 million shares and an aggregate amount of HKD 1.089 billion [1]. Group 1: Share Buyback Details - Tencent Holdings repurchased 1.049 million shares for HKD 636 million, with a highest price of HKD 608.50 and a lowest price of HKD 604.50, bringing its total buyback amount for the year to HKD 70.501 billion [1][2]. - Xiaomi Group-W repurchased 4.8 million shares for HKD 204 million, with a highest price of HKD 42.72 and a lowest price of HKD 42.14, totaling HKD 4.147 billion for the year [1][2]. - China COSCO Shipping repurchased 3 million shares for HKD 41.21 million, with a highest price of HKD 13.89 and a lowest price of HKD 13.67, totaling HKD 6.155 billion for the year [1][2]. Group 2: Notable Buybacks - The largest buyback amount on December 8 was by Tencent Holdings at HKD 636 million, followed by Xiaomi Group-W at HKD 204 million [1][2]. - The highest number of shares repurchased on December 8 was by China Feihe, with 7 million shares, followed by Jinxin Fertility and Xiaomi Group-W with 5.9285 million and 4.8 million shares, respectively [1][2]. Group 3: Other Companies Involved - Geely Automobile conducted its first buyback of the year, repurchasing shares for HKD 27.12 million [2]. - Other companies with significant buybacks included Kuaishou-W and Jinxin Fertility, with respective amounts of HKD 2.995 million and HKD 1.484 million [2].